Retham Technologies seeks to revolutionize the diagnosis of Heparin induced thrombocytopenia (HIT) by enabling rapid
#18 of 157 biotech startups
▲ 2 since the last ranking
Ranked 6:02 AM PT · Thu, Nov 19
Established
Retham Technologies seeks to revolutionize the diagnosis of Heparin induced thrombocytopenia (HIT) by enabling rapid and accurate HIT testing
If a fact is wrong, or you want the profile removed, tell us: we act on every request within 2 business days.